Endoscopic Sphenopalatine Artery Ligation

A 58-year-old female on Plavix presented to the ER with recurrent left-sided epistaxis after two prior endoscopic control of epistaxis at an outside hospital.  The patient’s hemoglobin and hematocrit at presentation were 8.3 gm/dL and 25.4%.  Given the unilateral presentation, antiplatelet therapy, and recently failed endoscopic control, the patient was taken to the operating room for transnasal endoscopic sphenopalatine artery ligation (TESPAL) with bipolar cautery.

Contributors:

Mathew Geltzeiler and Eric Wang

Reconstruction of Transcribriform Skull Base Defects

A 51 year-old male presented to an outside otolaryngologist with recurrent facial pain and congestion. He was found to have a left-sided nasal mass.  A work-up was performed, complete with biopsy, which was diagnosed as non-intestinal type adenocarcinoma.  He underwent resection via the endoscopic endonasal transcribriform approach.  In this video publication, we present our preferred method of reconstruction for sinonasal malignancies treated by endoscopic transcribriform resection using a multilayered closure with the following: a subdural DuraGen inlay graft, a fascia lata onlay graft, and an extradural, extracranial onlay pericranial flap via nasionectomy.  A lumbar drain was placed at the end of the case for CSF diversion until the fifth postoperative day.

Contributors:

Paul A. Gardner, MD, Eric W. Wang, MD, Juan C. Fernandez-Miranda, MD, and Carl H. Snyderman, MD, MBA

The Extended Nasoseptal Flap

A 31 year-old male presented with diplopia and was found to have left sixth nerve palsy on physical examination.  Work-up with MRI revealed a hypointense mass on T2 images involving the mid to lower clivus with penetration of the posterior fossa dura.  The patient had no complaints of nasal obstruction, no prior nasal surgery or nasal trauma.  Intraoperative frozen section analysis revealed chordoma.

Author Note: minute 3:41 “rostrum” was spelled incorrectly.

Contributor:

Eric Wang

Your 30-second teaser has ended. Log in or sign up to watch the full video.

Newsletter Signup

"*" indicates required fields